Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection—The Hawaii Aging with HIV Cohort

References

• Brew B J. Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS 2004; 18(Suppl 1)S75–S78, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Chiesi A, Vella S, Dally L G, Pedersen C, Danner S, Johnson A M, Schwander S, Goebel F D, Glauser M, Antunes F, et al. Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 11: 39–44, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Childs E A, Lyles R H, Selnes O A, Chen B, Miller E N, Cohen B A, Becker J T, Mellors J, McArthur J C. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 1999; 52: 607–613, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Chow D C, Souza S A, Chen R, Richmond-Crum S M, Grandinetti A, Shikuma C. Elevated blood pressure in HIV-infected individuals receiving highly active antiretroviral therapy. HIV Clin Trials 2003; 4: 411–416, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• D'Amico R, Yang Y, Mildvan D, Evans S R, Schnizlein-Bick C T, Hafner R, Webb N, Basar M, Zackin R, Jacobson M A. Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067. J Clin Immunol 2005; 25: 106–115, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ellis R J, Moore D J, Childers M E, Letendre S, McCutchan J A, Wolfson T, Spector S A, Hsia K, Heaton R K, Grant I. Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA. Arch Neurol 2002; 59: 923–928, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• el-Sadr W, Gettler J. Unrecognized human immunodeficiency virus infection in the elderly. Arch Intern Med 1995; 155: 184–186, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hawaii Department of Health. HIV/AIDS Surveillance Semi-Annual Report. 2005
   Google Scholar
• Kusdra L, McGuire D, Pulliam L. Changes in monocyte/macrophage neurotoxicity in the era of HAART: implications for HIV-associated dementia. AIDS 2002; 16: 31–38, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lichtenstein K A, Armon C, Baron A, Moorman A C, Wood K C, Holmberg S D. Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort. Clin Infect Dis 2005; 40: 148–157, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Masliah E, DeTeresa R M, Mallory M E, Hansen L A. Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS 2000; 14: 69–74, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Mauss S, Corzillius M, Wolf E, Schwenk A, Adam A, Jaeger H, Knechten H, Goelz J, Goetzenich A. Risk factors for the HIV associated lipodystrophy syndrome in a closed cohort of patients after 3 years of antiretroviral treatment. HIV Med 2002; 3: 49–55, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• McArthur J C, Brew B J, Nath A. Neurological complications of HIV infection. Lancet Neurol 2005; 4: 543–555, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Miller V, Mocroft A, Reiss P, Katlama C, Papadopoulos A I, Katzenstein T, van Lunzen J, Antunes F, Phillips A N, Lundgren J D. Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA study. Ann Intern Med 1999; 130: 570–577, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Sacktor N, McDermott M P, Marder K, Schifitto G, Selnes O A, McArthur J C, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida J A, Cohen B, Epstein L. HIV-associated cognitive impairment before and after the advent of combination therapy. J NeuroVirol 2002; 8: 136–142, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Tozzi V, Balestra P, Lorenzini P, Bellagamba R, Galgani S, Corpolongo A, Vlassi C, Larussa D, Zaccarelli M, Noto P, Visco-Comandini U, Giulianelli M, Ippolito G, Antinori A, Narciso P. Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort. J NeuroVirol 2005; 11: 265–273, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Valcour V, Shikuma C, Shiramizu B, Watters M, Poff P, Selnes O, Holck P, Grove J, Sacktor N. Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. Neurology 2004; 63: 822–827, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Watters M R, Poff P W, Shiramizu B T, Holck P S, Fast K M, Shikuma C M, Valcour V G. Symptomatic distal sensory polyneuropathy in HIV after age 50. Neurology 2004; 62: 1378–1383, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Working Group of the American Academy of Neurology AIDS Task Force. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 1991; 41: 778–785, [CSA]
   PubMed Web of Science ®Google Scholar